Last reviewed · How we verify
PF-05221304 administered Day 1-14 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
PF-05221304 administered Day 1-14 (PF-05221304 administered Day 1-14) — Pfizer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PF-05221304 administered Day 1-14 TARGET | PF-05221304 administered Day 1-14 | Pfizer | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PF-05221304 administered Day 1-14 CI watch — RSS
- PF-05221304 administered Day 1-14 CI watch — Atom
- PF-05221304 administered Day 1-14 CI watch — JSON
- PF-05221304 administered Day 1-14 alone — RSS
Cite this brief
Drug Landscape (2026). PF-05221304 administered Day 1-14 — Competitive Intelligence Brief. https://druglandscape.com/ci/pf-05221304-administered-day-1-14. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab